SCM
RVNC

Stonepine Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Stonepine Capital Management’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-23,264
Closed -$70.7K – 74
2024
Q4 		$70.7K Sell
23,264
-796,736
-97% -$2.42M 0.06% 51
2024
Q3 		$4.26M Sell
820,000
-1,980,000
-71% -$10.3M 2.69% 10
2024
Q2 		$7.2M Buy
2,800,000
+823,658
+42% +$2.12M 6.57% 5
2024
Q1 		$9.72M Buy
+1,976,342
New +$9.72M 7.71% 5